Cisen Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7,403	7,842	6,221	6,601	5,668	5,978
Market Cap Growth	21.56%	26.05%	-5.76%	16.46%	-5.19%	-4.03%
Enterprise Value	4,142	4,581	3,782	4,082	3,364	3,917
Last Close Price	16.35	17.32	13.40	13.65	11.48	11.87
PE Ratio	17.58	18.61	12.22	12.66	16.20	17.89
Forward PE	-	46.95	46.95	46.95	46.95	46.95
PS Ratio	2.15	2.28	1.56	1.48	1.39	1.58
PB Ratio	1.20	1.27	1.04	1.15	1.06	1.18
P/TBV Ratio	1.24	1.32	1.08	1.20	1.11	1.23
P/FCF Ratio	18.43	19.53	13.26	15.23	25.40	32.74
P/OCF Ratio	15.87	16.81	10.90	14.63	21.94	25.59
EV/Sales Ratio	1.20	1.33	0.95	0.92	0.83	1.03
EV/EBITDA Ratio	7.17	7.96	5.53	5.22	6.47	9.07
EV/EBIT Ratio	11.00	12.16	8.10	7.41	11.55	18.28
EV/FCF Ratio	10.31	11.41	8.06	9.41	15.08	21.45
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.03	0.03
Debt / EBITDA Ratio	0.07	0.07	0.17	0.22	0.30	0.33
Debt / FCF Ratio	0.11	0.11	0.25	0.39	0.71	0.79
Net Debt / Equity Ratio	-0.53	-0.53	-0.45	-0.45	-0.49	-0.45
Net Debt / EBITDA Ratio	-5.73	-5.73	-3.92	-3.33	-5.05	-5.28
Net Debt / FCF Ratio	-8.22	-8.22	-5.71	-6.01	-11.76	-12.49
Asset Turnover	-	-	0.54	0.63	0.62	0.60
Inventory Turnover	-	-	2.39	2.97	3.11	2.96
Quick Ratio	-	-	2.72	3.02	3.17	2.86
Current Ratio	-	-	3.33	3.63	3.70	3.40
Return on Equity (ROE)	6.99%	6.99%	8.76%	9.45%	6.77%	6.78%
Return on Assets (ROA)	-	-	3.92%	4.87%	2.76%	2.14%
Return on Invested Capital (ROIC)	11.17%	10.42%	12.90%	16.48%	10.17%	7.92%
Return on Capital Employed (ROCE)	-	-	7.70%	9.20%	5.30%	4.20%
Earnings Yield	5.69%	5.37%	8.18%	7.90%	6.17%	5.59%
FCF Yield	5.43%	5.12%	7.54%	6.57%	3.94%	3.05%
Dividend Yield	2.30%	-	3.28%	3.19%	2.92%	2.53%
Payout Ratio	43.42%	43.42%	59.85%	29.95%	39.87%	36.13%
Buyback Yield / Dilution	0.31%	0.31%	-0.23%	0.25%	-0.65%	0.18%
Total Shareholder Return	2.61%	0.31%	3.05%	3.45%	2.27%	2.71%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.